Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Longboard Pharmaceuticals (LBPH)
NASDAQ:LBPH
RESEARCH TOOLSreports
Holding LBPH?
Track your performance easily
See the Price Targets and Ratings of:
LBPH Analyst Ratings
Moderate Buy
2 Buy
5 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LBPH Stock 12 Month Forecast
Average Price Target
$64.00
▲(7.22% Upside)
| Highest Price Target$80.00 | Average Price Target$64.00 | Lowest Price Target$60.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Truist Financial
Assigned
11/11/24
Robert W. Baird
Downgraded
11/11/24
H.C. Wainwright
Reiterated
10/15/24
Cantor Fitzgerald
Downgraded
10/14/24
B.Riley Financial
Downgraded
10/14/24
Wedbush
Downgraded
10/14/24
Citi
Reiterated
08/02/24
JonesTrading
$35
Buy
-41.36%
Downside
Reiterated
01/02/24
Buy Rating for Longboard Pharmaceuticals Amid Strong Clinical Results for Bexicaserin
Guggenheim
$16→$32
Buy
-46.39%
Downside
Reiterated
01/02/24
Longboard Pharmaceuticals price target raised to $32 from $16 at GuggenheimLongboard Pharmaceuticals price target raised to $32 from $16 at Guggenheim
―
Evercore ISI
―
Buy
―
Reiterated
09/17/24
We think choosing only TID for the P3 is a positive update, since exposure-response was an unknown for us. We suspect BID dosing would’ve been fine, but we appreciate that this potential risk was just taken off the table altogether. 3. Titration regimen: longer steps (21d titration period) plus additional education/coaching around tolerability should significantly reduce discontinuations.
Best Analysts Covering Longboard Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy LBPH and Sell After:
1 Month
xxx
Success Rate
11/21 ratings generated profit
Average Return
+7.12%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 52.38% of your transactions generating a profit, with an average return of +7.12% per trade.
3 Months
xxx
Success Rate
12/21 ratings generated profit
Average Return
+51.26%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +51.26% per trade.
1 Year
Success Rate
21/21 ratings generated profit
Average Return
+203.20%
reiterated a buy rating last month
Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +203.20% per trade.
2 Years
xxx
Success Rate
21/21 ratings generated profit
Average Return
+430.07%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +430.07% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LBPH Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
12
12
14
10
7
Buy
4
4
6
5
3
Hold
0
0
0
5
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
16
20
20
17
Each month's total comprises the sum of three months' worth of ratings.
LBPH Financial Forecast
LBPH Stock Forecast FAQ
What is LBPH’s average 12-month price target, according to analysts?
Based on analyst ratings, Longboard Pharmaceuticals’s 12-month average price target is $64.00.
What is LBPH’s upside potential, based on the analysts’ average price target?
Longboard Pharmaceuticals has 7.22% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LBPH a Buy, Sell or Hold?
Longboard Pharmaceuticals has a consensus rating of Moderate Buy which is based on 2 buy ratings, 5 hold ratings and 0 sell ratings.
What is Longboard Pharmaceuticals’s price target?
The average price target for Longboard Pharmaceuticals is $64.00. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $80.00 ,the lowest forecast is $60.00. The average price target represents 7.22% Increase from the current price of $59.69.
The highest analyst price target is $80.00 ,the lowest forecast is $60.00. The average price target represents 7.22% Increase from the current price of $59.69.
What do analysts say about Longboard Pharmaceuticals?
Longboard Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of LBPH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.